These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 5614091)
21. [A case of Hodgkin's disease associated with amyloidosis (author's transl)]. Osamura K; Kanayama S; Yamazaki H; Nakata T; Nishio A; Hosoda M; Haruyama H; Yamazaki Y; Katsuki A; Sugishima K; Ijichi H; Isemura T Rinsho Ketsueki; 1979 Nov; 20(11):1505-11. PubMed ID: 537171 [No Abstract] [Full Text] [Related]
22. Hodgkin's lymphoma with concurrent systemic amyloidosis, presenting as acute renal failure, following lymphomatoid papulosis. Amir AR; Sheikh SS J Nephrol; 2006; 19(3):361-5. PubMed ID: 16874698 [TBL] [Abstract][Full Text] [Related]
23. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group. Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V; J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249 [TBL] [Abstract][Full Text] [Related]
24. [Pulmonary amyloidosis of the AA type associated with Hodgkin's disease]. Pfitzenmeyer P; Massin F; Fargeot P; Bonneau P; Michiels R; Jeannin L Rev Med Interne; 1988; 9(5):524-7. PubMed ID: 3067298 [No Abstract] [Full Text] [Related]
25. Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study Group. Behringer K; Breuer K; Reineke T; May M; Nogova L; Klimm B; Schmitz T; Wildt L; Diehl V; Engert A; J Clin Oncol; 2005 Oct; 23(30):7555-64. PubMed ID: 16234521 [TBL] [Abstract][Full Text] [Related]
26. Long-term survival of patients with Hodgkin's disease. Treatment with cyclophosphamide, vinblastine, procarbazine, and prednisone. Gibbs GE; Peterson BA; Kennedy BJ; Vosika G; Bloomfield CD Arch Intern Med; 1981 Jun; 141(7):897-900. PubMed ID: 7235809 [TBL] [Abstract][Full Text] [Related]
27. Long-term outcome of children and adolescents treated with the COPP-ABV hybrid protocol for Hodgkin's disease: balance of risks. Klumb CE; Carriço MK; de Rezende LM; Byington R; Bordallo MA; Bigni RS; Apa AG; Dobbin JA Clin Oncol (R Coll Radiol); 2007 Oct; 19(8):628-9. PubMed ID: 17662581 [No Abstract] [Full Text] [Related]
28. [Acute generalized amyloidosis as a complication of the rapidly developing form of lymphogranulomatosis]. Dobrin BIu; Solodovnik EG; Taloverova ZI; Shuper NB Vrach Delo; 1976 Jul; (7):103-5. PubMed ID: 997440 [No Abstract] [Full Text] [Related]
31. [Nephrotic syndrome as a paraneoplastic symptom of Hodgkin's disease in two children]. Raphaël MF; Groothoff JW; van den Berg H Ned Tijdschr Geneeskd; 2002 Aug; 146(34):1595-8. PubMed ID: 12224484 [TBL] [Abstract][Full Text] [Related]
32. Long-term results of an intensive regimen: VEBEP plus involved-field radiotherapy in advanced Hodgkin's disease. Viviani S; Bonfante V; Santoro A; Zanini M; Devizzi L; Di Russo AD; Soncini F; Villani F; Ragni G; Valagussa P; Bonadonna G Cancer J Sci Am; 1999; 5(5):275-82. PubMed ID: 10526668 [TBL] [Abstract][Full Text] [Related]
33. Approaches to improving the chemotherapy of Hodgkin's disease. Frei E; DeVita VT; Moxley JH; Carbone PP Cancer Res; 1966 Jun; 26(6):1284-9. PubMed ID: 5947352 [No Abstract] [Full Text] [Related]
34. Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease. Gobbi PG; Broglia C; Bertè R; Petrilli MP; Molica S; Angrilli F; Iannitto E; Ghirardelli ML; Di Renzo N; Cavanna L; Ascari E Haematologica; 2000 Jul; 85(7):722-8. PubMed ID: 10897124 [TBL] [Abstract][Full Text] [Related]
35. Long-term follow-up of two chemotherapy protocols in Hodgkin's disease. Pavlovsky S; Morgenfeld M; Somoza N; Magnasco J; Sackmann Muriel F; Cavagnaro F; Suárez A; Barros CA; Saslavsky J; Garay G; Palau M; Besuschio SC Medicina (B Aires); 1981; 41 Suppl():15-21. PubMed ID: 6896551 [No Abstract] [Full Text] [Related]
36. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma]. Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685 [TBL] [Abstract][Full Text] [Related]
38. Leimyosarcoma of the urinary bladder. 13 years after cyclophosphamide therapy for Hodgkin's disease. Seo IS; Clark SA; McGovern FD; Clark DL; Johnson EH Cancer; 1985 Apr; 55(7):1597-603. PubMed ID: 3978554 [TBL] [Abstract][Full Text] [Related]
39. Obstructive jaundice secondary to Hodgkin's disease. Abe H; Kubota K; Makuuchi M Am J Gastroenterol; 1997 Mar; 92(3):526-7. PubMed ID: 9068487 [No Abstract] [Full Text] [Related]
40. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY. Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]